UniProt ID | PDP1_HUMAN | |
---|---|---|
UniProt AC | Q9P0J1 | |
Protein Name | [Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial | |
Gene Name | PDP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 537 | |
Subcellular Localization | Mitochondrion matrix. | |
Protein Description | Catalyzes the dephosphorylation and concomitant reactivation of the alpha subunit of the E1 component of the pyruvate dehydrogenase complex.. | |
Protein Sequence | MPAPTQLFFPLIRNCELSRIYGTACYCHHKHLCCSSSYIPQSRLRYTPHPAYATFCRPKENWWQYTQGRRYASTPQKFYLTPPQVNSILKANEYSFKVPEFDGKNVSSILGFDSNQLPANAPIEDRRSAATCLQTRGMLLGVFDGHAGCACSQAVSERLFYYIAVSLLPHETLLEIENAVESGRALLPILQWHKHPNDYFSKEASKLYFNSLRTYWQELIDLNTGESTDIDVKEALINAFKRLDNDISLEAQVGDPNSFLNYLVLRVAFSGATACVAHVDGVDLHVANTGDSRAMLGVQEEDGSWSAVTLSNDHNAQNERELERLKLEHPKSEAKSVVKQDRLLGLLMPFRAFGDVKFKWSIDLQKRVIESGPDQLNDNEYTKFIPPNYHTPPYLTAEPEVTYHRLRPQDKFLVLATDGLWETMHRQDVVRIVGEYLTGMHHQQPIAVGGYKVTLGQMHGLLTERRTKMSSVFEDQNAATHLIRHAVGNNEFGTVDHERLSKMLSLPEELARMYRDDITIIVVQFNSHVVGAYQNQE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
43 | Methylation | SSYIPQSRLRYTPHP CCCCCHHHCCCCCCC | 20.24 | 24411441 | |
46 | Phosphorylation | IPQSRLRYTPHPAYA CCHHHCCCCCCCCCC | 29.25 | 18083107 | |
59 | Ubiquitination | YATFCRPKENWWQYT CCCEECCCCCCCCCC | 44.31 | - | |
74 | Phosphorylation | QGRRYASTPQKFYLT CCCCCCCCCCEEECC | 22.90 | 28985074 | |
77 | Ubiquitination | RYASTPQKFYLTPPQ CCCCCCCEEECCCHH | 36.86 | 21906983 | |
79 | Phosphorylation | ASTPQKFYLTPPQVN CCCCCEEECCCHHHH | 19.39 | - | |
87 | Phosphorylation | LTPPQVNSILKANEY CCCHHHHHHHHHCCC | 30.37 | 24719451 | |
87 | O-linked_Glycosylation | LTPPQVNSILKANEY CCCHHHHHHHHHCCC | 30.37 | 29351928 | |
90 | Ubiquitination | PQVNSILKANEYSFK HHHHHHHHHCCCEEE | 47.71 | 21906983 | |
94 | Phosphorylation | SILKANEYSFKVPEF HHHHHCCCEEECCCC | 21.15 | - | |
97 | Ubiquitination | KANEYSFKVPEFDGK HHCCCEEECCCCCCC | 51.44 | 21906983 | |
97 | Acetylation | KANEYSFKVPEFDGK HHCCCEEECCCCCCC | 51.44 | 25038526 | |
104 | Acetylation | KVPEFDGKNVSSILG ECCCCCCCCHHHHHC | 56.89 | 63650813 | |
104 | Ubiquitination | KVPEFDGKNVSSILG ECCCCCCCCHHHHHC | 56.89 | 21906983 | |
194 | Ubiquitination | LPILQWHKHPNDYFS HHHHHHCCCCCCCCC | 58.77 | 21906983 | |
199 | Phosphorylation | WHKHPNDYFSKEASK HCCCCCCCCCHHHHH | 19.18 | - | |
202 | Ubiquitination | HPNDYFSKEASKLYF CCCCCCCHHHHHHHH | 47.61 | 21906983 | |
202 | Acetylation | HPNDYFSKEASKLYF CCCCCCCHHHHHHHH | 47.61 | 19608861 | |
206 | Ubiquitination | YFSKEASKLYFNSLR CCCHHHHHHHHHHHH | 55.01 | 21906983 | |
227 | Ubiquitination | IDLNTGESTDIDVKE HHCCCCCCCCCHHHH | 32.50 | 19608861 | |
227 | Acetylation | IDLNTGESTDIDVKE HHCCCCCCCCCHHHH | 32.50 | 19608861 | |
233 | Ubiquitination | ESTDIDVKEALINAF CCCCCHHHHHHHHHH | 33.26 | - | |
241 | Ubiquitination | EALINAFKRLDNDIS HHHHHHHHHCCCCCC | 50.03 | 21906983 | |
241 | Acetylation | EALINAFKRLDNDIS HHHHHHHHHCCCCCC | 50.03 | 30591195 | |
292 | Phosphorylation | HVANTGDSRAMLGVQ EEEECCCCCCEEEEE | 24.23 | - | |
326 | Ubiquitination | ERELERLKLEHPKSE HHHHHHHHCCCCHHH | 59.04 | 21906983 | |
326 | Acetylation | ERELERLKLEHPKSE HHHHHHHHCCCCHHH | 59.04 | 22362505 | |
331 | Acetylation | RLKLEHPKSEAKSVV HHHCCCCHHHHHHHH | 63.94 | 22362515 | |
331 | Ubiquitination | RLKLEHPKSEAKSVV HHHCCCCHHHHHHHH | 63.94 | - | |
335 | Ubiquitination | EHPKSEAKSVVKQDR CCCHHHHHHHHCHHH | 39.47 | 21906983 | |
335 | Acetylation | EHPKSEAKSVVKQDR CCCHHHHHHHHCHHH | 39.47 | 22362525 | |
339 | Ubiquitination | SEAKSVVKQDRLLGL HHHHHHHCHHHHHHH | 44.30 | 21906983 | |
357 | Ubiquitination | FRAFGDVKFKWSIDL CHHHCCCEEEEEEEH | 46.06 | 21906983 | |
357 | Acetylation | FRAFGDVKFKWSIDL CHHHCCCEEEEEEEH | 46.06 | 63650811 | |
359 | Ubiquitination | AFGDVKFKWSIDLQK HHCCCEEEEEEEHHH | 34.02 | 21906983 | |
366 | Sumoylation | KWSIDLQKRVIESGP EEEEEHHHHHHHHCC | 56.80 | - | |
366 | Ubiquitination | KWSIDLQKRVIESGP EEEEEHHHHHHHHCC | 56.80 | 21906983 | |
381 | Phosphorylation | DQLNDNEYTKFIPPN CCCCCCCCCCCCCCC | 22.83 | - | |
383 | Ubiquitination | LNDNEYTKFIPPNYH CCCCCCCCCCCCCCC | 40.15 | 21906983 | |
411 | Ubiquitination | HRLRPQDKFLVLATD ECCCCCCEEEEEECC | 35.04 | 21906983 | |
411 | Acetylation | HRLRPQDKFLVLATD ECCCCCCEEEEEECC | 35.04 | 25038526 | |
452 | Ubiquitination | PIAVGGYKVTLGQMH CEEECCEEEEHHHHC | 31.83 | 21906983 | |
468 | Ubiquitination | LLTERRTKMSSVFED HHHHHHHHHHHHCCC | 34.67 | 21906983 | |
468 | Acetylation | LLTERRTKMSSVFED HHHHHHHHHHHHCCC | 34.67 | 63650807 | |
502 | Ubiquitination | VDHERLSKMLSLPEE CCHHHHHHHHCCHHH | 48.75 | 21906983 | |
502 | Acetylation | VDHERLSKMLSLPEE CCHHHHHHHHCCHHH | 48.75 | 63650809 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PDP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PDP1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ODPA_HUMAN | PDHA1 | physical | 24486017 | |
THIL_HUMAN | ACAT1 | physical | 24486017 | |
SIR3_HUMAN | SIRT3 | physical | 24486017 | |
FGFR1_HUMAN | FGFR1 | physical | 24486017 | |
EGFR_HUMAN | EGFR | physical | 24486017 | |
COR1C_HUMAN | CORO1C | physical | 27880917 | |
PDPR_HUMAN | PDPR | physical | 27880917 | |
MPPA_HUMAN | PMPCA | physical | 27880917 | |
MPPB_HUMAN | PMPCB | physical | 27880917 | |
SPTN1_HUMAN | SPTAN1 | physical | 27880917 | |
SPTB2_HUMAN | SPTBN1 | physical | 27880917 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
608782 | Pyruvate dehydrogenase phosphatase deficiency (PDP deficiency) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-202, AND MASS SPECTROMETRY. |